NCT00002679View on ClinicalTrials.gov

Adjuvant High-Dose, Sequential Chemotherapy in Treating Patients With Resected Breast Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

89

Participants

Timeline

Start Date

February 28, 1994

Primary Completion Date

January 31, 2002

Study Completion Date

January 31, 2002

Conditions
Breast Cancer
Interventions
BIOLOGICAL

filgrastim

DRUG

cyclophosphamide

DRUG

doxorubicin hydrochloride

DRUG

paclitaxel

DRUG

tamoxifen citrate

RADIATION

radiation therapy

Trial Locations (1)

06520-8028

Yale Comprehensive Cancer Center, New Haven

All Listed Sponsors
lead

Yale University

OTHER